4 min listen
Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn
Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn
ratings:
Length:
26 minutes
Released:
Feb 27, 2023
Format:
Podcast episode
Description
Filament Health produces non-synthetic psychedelic substances for research and treatment. They’re known as the first lab to have non-synthesized psilocybin for clinical trials and hope to show the efficacy of naturally derived psychedelics. Benjamin explains some current clinical trials as they test out the difference between oral and sublingual administration of psilocybin.We also dive into the Special Access Program and how to apply to Health Canada for access to non-approved drugs for experimental treatments of depression.You can keep in touch with Benjamin on Twitter (@benlightburn) or with Filament Health on Twitter (@FilamentHealth), Instagram (@FilamentHealth), or on their website (filament.health)
Released:
Feb 27, 2023
Format:
Podcast episode
Titles in the series (100)
Ronan Levy - Investing in Psychedelics: Hear from Ronan Levy, Founder and Executive Chairman of Field Trip Health, who joined Global Trac Solutions, Inc. CEO, David Flores, on the Psychedelic Spotlight podcast, about what separates Field Trip Health from the competition within their sector and the progress they are making with the development of FT104. by Psychedelic Spotlight Podcast